.png)
Artificial Intelligence In Drug Discovery Market by Drug Type and Application- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 142 Category: Pharma & Healthcare Report Code : HC0912939
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Artificial Intelligence In Drug Discovery MarketBy Drug Type (Small Molecule, Large Molecules), Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Other Applications)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Artificial Intelligence In Drug Discovery Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Artificial Intelligence In Drug Discovery helps in direct research and reduce discovery times and provide a streamlined and automated approach across the various stages of drug discovery.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Artificial Intelligence In Drug Discovery Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Microsoft
- NVIDIA Corporation
- IBM Corporation
- Atomwise, Inc.
- DEEP GENOMICS
- Cloud Pharmaceuticals, Inc.
- InsilicoMedicine
- BenevolentAILtd
- Exscientia
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Artificial Intelligence In Drug Discovery Market, ByDrugType, Estimates and Forecast, 2017-2027 ($Million)
o Small Molecule
o Large Molecules
· Artificial Intelligence In Drug Discovery Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Immuno-Oncology
o Neurodegenerative Diseases
o Cardiovascular Disease
o Metabolic Diseases
o Other Applications
· Artificial Intelligence In Drug Discovery Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Microsoft
o NVIDIA Corporation
o IBM Corporation
o Atomwise, Inc.
o DEEP GENOMICS
o Cloud Pharmaceuticals, Inc.
o Insilico Medicine
o BenevolentAI Ltd
o Exscientia
· Artificial Intelligence In Drug Discovery Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Artificial Intelligence In Drug Discovery Market , By Country
o U.S. Artificial Intelligence In Drug Discovery Market
o Canada Artificial Intelligence In Drug Discovery Market
o Mexico Artificial Intelligence In Drug Discovery Market
o Europe
§ Europe Artificial Intelligence In Drug Discovery Market , By Country
o UK Artificial Intelligence In Drug Discovery Market
o Germany Artificial Intelligence In Drug Discovery Market
o France Artificial Intelligence In Drug Discovery Market
o Russia Artificial Intelligence In Drug Discovery Market
o Italy Artificial Intelligence In Drug Discovery Market
o Rest of Europe Artificial Intelligence In Drug Discovery Market
o Asia-Pacific
§ Asia-Pacific Artificial Intelligence In Drug Discovery Market , By Country
o China Artificial Intelligence In Drug Discovery Market
o Japan Artificial Intelligence In Drug Discovery Market
o South Korea Artificial Intelligence In Drug Discovery Market
o India Artificial Intelligence In Drug Discovery Market
o Southeast Asia Artificial Intelligence In Drug Discovery Market
o Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Market
o South America
§ South America Artificial Intelligence In Drug Discovery Market
o Brazil Artificial Intelligence In Drug Discovery Market
o Argentina Artificial Intelligence In Drug Discovery Market
o Columbia Artificial Intelligence In Drug Discovery Market
o Rest of South America Artificial Intelligence In Drug Discovery Market
o Middle East and Africa
§ Middle East and Africa Artificial Intelligence In Drug Discovery Market
o Saudi Arabia Artificial Intelligence In Drug Discovery Market
o UAE Artificial Intelligence In Drug Discovery Market
o Egypt Artificial Intelligence In Drug Discovery Market
o Nigeria Artificial Intelligence In Drug Discovery Market
o South Africa Artificial Intelligence In Drug Discovery Market
o TurkeyArtificial Intelligence In Drug Discovery Market
o Rest of MEA Artificial Intelligence In Drug Discovery Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Artificial Intelligence In Drug Discovery Market, By Drug Type
5.1. Introduction
5.2. Global Artificial Intelligence In Drug Discovery Revenue and Market Share by Drug Type (2017-2021)
5.2.1. Global Artificial Intelligence In Drug Discovery Revenue and Revenue Share by Drug Type (2017-2021)
5.3. Small Molecule
5.3.1. Global Small Molecule Revenue and Growth Rate (2017-2021)
5.4. Large Molecules
5.4.1. Global Large Molecules Revenue and Growth Rate (2017-2021)
6. Artificial Intelligence In Drug Discovery Market, By Applications
6.1. Introduction
6.2. Global Artificial Intelligence In Drug Discovery Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Artificial Intelligence In Drug Discovery Revenue and Revenue Share by Applications (2017-2021)
6.3. Immuno-Oncology
6.3.1. Global Immuno-Oncology Revenue and Growth Rate (2017-2021)
6.4. Neurodegenerative Diseases
6.4.1. Global Neurodegenerative Diseases Revenue and Growth Rate (2017-2021)
6.5. Cardiovascular Disease
6.5.1. Global Cardiovascular Disease Revenue and Growth Rate (2017-2021)
6.6. Metabolic Diseases
6.6.1. Global Metabolic Diseases Revenue and Growth Rate (2017-2021)
6.7. Other Applications
6.7.1. Global Other Applications Revenue and Growth Rate (2017-2021)
7. Artificial Intelligence In Drug Discovery Market, By Region
7.1. Introduction
7.2. Global Artificial Intelligence In Drug Discovery Revenue and Market Share by Regions
7.2.1. Global Artificial Intelligence In Drug Discovery Revenue by Regions (2017-2021)
7.3. North America Artificial Intelligence In Drug Discovery by Countries
7.3.1. North America Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2021)
7.3.2. North America Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Artificial Intelligence In Drug Discovery by Countries
7.4.1. Europe Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2021)
7.4.2. Europe Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Artificial Intelligence In Drug Discovery by Countries
7.5.1. Asia-Pacific Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Artificial Intelligence In Drug Discovery by Countries
7.6.1. South America Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2021)
7.6.2. South America Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Artificial Intelligence In Drug Discovery by Countries
7.7.1. Middle East and Africa Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Microsoft
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. NVIDIA Corporation
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. IBM Corporation
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Atomwise, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. DEEP GENOMICS
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Cloud Pharmaceuticals, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Insilico Medicine
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. BenevolentAI Ltd
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Exscientia
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.1. Global Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Artificial Intelligence In Drug Discovery Market Forecast by Regions (2022-2027)
9.2.1. North America Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.1.1. United States Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.1.2. Canada Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.1.3. Mexico Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2. Europe Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.1. Germany Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.2. France Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.3. UK Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.4. Russia Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.5. Italy Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3. Asia-Pacific Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.1. China Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.2. Japan Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.3. Korea Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.4. India Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.4. South America Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.4.1. Brazil Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.4.2. Argentina Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.4.3. Columbia Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.4.4. Rest of South America Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5. Middle East and Africa Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.3. Egypt Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.4. Nigeria Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.5. South Africa Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.6. Turkey Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Market Forecast (2022-2027)
9.3. Artificial Intelligence In Drug Discovery Market Forecast by Drug Type (2022-2027)
9.3.1. Artificial Intelligence In Drug Discovery Forecast by Drug Type (2022-2027)
9.3.2. Artificial Intelligence In Drug Discovery Market Share Forecast by Drug Type (2022-2027)
9.4. Artificial Intelligence In Drug Discovery Market Forecast by Applications (2022-2027)
9.4.1. Artificial Intelligence In Drug Discovery Forecast by Applications (2022-2027)
9.4.2. Artificial Intelligence In Drug Discovery Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Artificial Intelligence In Drug Discovery Revenue and Revenue Share by Drug Type (2017-2019)
Figure Global Small Molecule Revenue and Growth Rate (2017-2019)
Figure Global Large Molecules Revenue and Growth Rate (2017-2019)
Table Global Artificial Intelligence In Drug Discovery Revenue and Revenue Share by Applications (2017-2019)
Figure Global Immuno-Oncology Revenue and Growth Rate (2017-2019)
Figure Global Neurodegenerative Diseases Revenue and Growth Rate (2017-2019)
Figure Global Cardiovascular Disease Revenue and Growth Rate (2017-2019)
Figure Global Metabolic Diseases Revenue and Growth Rate (2017-2019)
Figure Global Other Applications Revenue and Growth Rate (2017-2019)
Table Global Artificial Intelligence In Drug Discovery Revenue by Regions (2017-2019)
Figure North America Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure North America Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2019)
Figure North America Artificial Intelligence In Drug Discovery by Countries (2017-2019)
Figure North America Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2019)
Figure United States Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure United States Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Canada Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Mexico Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Europe Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2019)
Figure Europe Artificial Intelligence In Drug Discovery by Countries (2017-2019)
Figure Europe Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2019)
Figure Germany Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Germany Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure France Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure UK Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Russia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Italy Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Rest of Europe Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Asia-Pacific Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Artificial Intelligence In Drug Discovery by Countries (2017-2019)
Figure Asia-Pacific Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2019)
Figure China Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure China Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Japan Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Korea Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure India Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Southeast Asia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure South America Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2019)
Figure South America Artificial Intelligence In Drug Discovery by Countries (2017-2019)
Figure South America Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Brazil Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Argentina Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Columbia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Rest of South America Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Middle East and Africa Artificial Intelligence In Drug Discovery Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Artificial Intelligence In Drug Discovery by Countries (2017-2019)
Figure Middle East and Africa Artificial Intelligence In Drug Discovery Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Saudi Arabia Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure United Arab Emirates Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Egypt Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Nigeria Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure South Africa Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Turkey Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2017-2019)
Table Microsoft Artificial Intelligence In Drug Discovery Financial Overview
Table NVIDIA Corporation Artificial Intelligence In Drug Discovery Financial Overview
Table IBM Corporation Artificial Intelligence In Drug Discovery Financial Overview
Table Atomwise, Inc. Artificial Intelligence In Drug Discovery Financial Overview
Table DEEP GENOMICS Artificial Intelligence In Drug Discovery Financial Overview
Table Cloud Pharmaceuticals, Inc. Artificial Intelligence In Drug Discovery Financial Overview
Table Insilico Medicine Artificial Intelligence In Drug Discovery Financial Overview
Table BenevolentAI Ltd Artificial Intelligence In Drug Discovery Financial Overview
Table Exscientia Artificial Intelligence In Drug Discovery Financial Overview
Figure Global Artificial Intelligence In Drug Discovery Revenue (Millions USD) and Growth Rate (2019-2027)
Table Artificial Intelligence In Drug Discovery Market Forecast by Regions (2019-2027)
Figure North America Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure United States Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Canada Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Mexico Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Europe Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Germany Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure France Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure UK Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Russia Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Italy Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Rest of Europe Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Asia-Pacific Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure China Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Japan Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Korea Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure India Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Southeast Asia Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure South America Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Brazil Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Argentina Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Columbia Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Rest of South America Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Middle East and Africa Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Saudi Arabia Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure United Arab Emirates Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Egypt Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Nigeria Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure South Africa Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Turkey Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Artificial Intelligence In Drug Discovery Market Forecast (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Forecast by Drug Type (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Market Share Forecast by Drug Type (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Forecast by Drug Type (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Forecast by Applications (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Market Share Forecast by Applications (2019-2027)
Figure Global Artificial Intelligence In Drug Discovery Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|